Cargando…

Acute blood flow restricted exercise to treat Duchenne muscular dystrophy: would it be efficacious?

Detalles Bibliográficos
Autores principales:	Loenneke, Jeremy P., Thiebaud, Robert S., Abe, Takashi, Manfro, Igor G., Marin, Pedro J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655283/ https://www.ncbi.nlm.nih.gov/pubmed/23720637 http://dx.doi.org/10.3389/fphys.2013.00114

Ejemplares similares

Blood flow restriction pressure recommendations: a tale of two cuffs
por: Loenneke, Jeremy P., et al.
Publicado: (2013)

Implications of notch signaling in duchenne muscular dystrophy
por: Den Hartog, Lily, et al.
Publicado: (2022)

Blood Flow Restriction: How Does It Work?
por: Loenneke, Jeremy P., et al.
Publicado: (2012)

Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013)

Duchenne muscular dystrophy: disease mechanism and therapeutic strategies
por: Bez Batti Angulski, Addeli, et al.
Publicado: (2023)

Effects of Blood Flow Restricted Low-Intensity Concentric or Eccentric Training on Muscle Size and Strength
por: Yasuda, Tomohiro, et al.
Publicado: (2012)

Satellite cell contribution to disease pathology in Duchenne muscular dystrophy
por: Kodippili, Kasun, et al.
Publicado: (2023)

Response: Commentary: Can Blood Flow Restricted Exercise Cause Muscle Damage? Commentary on Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
por: Burr, Jamie F., et al.
Publicado: (2020)

Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
por: Patterson, Stephen D., et al.
Publicado: (2019)

The new challenge of “exercise + X″ therapy for Duchenne muscular dystrophy—Individualized identification of exercise tolerance and precise implementation of exercise intervention
por: Su, Yuhui, et al.
Publicado: (2022)

Corrigendum: Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety
por: Patterson, Stephen D., et al.
Publicado: (2019)

PTX3 Predicts Myocardial Damage and Fibrosis in Duchenne Muscular Dystrophy
por: Farini, Andrea, et al.
Publicado: (2020)

Abnormal Calcium Handling in Duchenne Muscular Dystrophy: Mechanisms and Potential Therapies
por: Mareedu, Satvik, et al.
Publicado: (2021)

Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression
por: Yedigaryan, Laura, et al.
Publicado: (2023)

Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells
por: Bertoni, Carmen
Publicado: (2014)

Duchenne muscular dystrophy disease severity impacts skeletal muscle progenitor cells systemic delivery
por: Saleh, Kholoud K., et al.
Publicado: (2023)

Precision Medicine and Exercise Therapy in Duchenne Muscular Dystrophy
por: Kostek, Matthew
Publicado: (2019)

Metformin Increases Sarcolemma Integrity and Ameliorates Neuromuscular Deficits in a Murine Model of Duchenne Muscular Dystrophy
por: Dong, Xia, et al.
Publicado: (2021)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Muscle Adaptations to High-Load Training and Very Low-Load Training With and Without Blood Flow Restriction
por: Jessee, Matthew B., et al.
Publicado: (2018)

Angiogenesis as a novel therapeutic strategy for Duchenne muscular dystrophy through decreased ischemia and increased satellite cells
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2014)

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2020)

A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation
por: Sato, Masae, et al.
Publicado: (2023)

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2022)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Gene Therapy for Duchenne Muscular Dystrophy
por: Elangkovan, Nertiyan, et al.
Publicado: (2021)

Family reflections: Duchenne Muscular Dystrophy
por: Gill, Omaira
Publicado: (2022)

Cardiac therapies for Duchenne muscular dystrophy
por: Shah, Md Nur Ahad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7a7tumt7d03etbvp2h7o9evcrj